We are live on ! Find out more
BC

Bartlett & Co Portfolio holdings

AUM $6.16B
1-Year Est. Return 20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
10 Year Est. Return
AUM
$6.16B
AUM Growth
+$590M
Cap. Flow
+$26M
Cap. Flow %
0.42%
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51

Sector Composition

Rank Sector Weight
1 Technology 20.28%
2 Healthcare 12.33%
3 Financials 11.49%
4 Industrials 9.08%
5 Consumer Staples 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAC icon
401
Macerich
MAC
$7.35B
$319K 0.01%
20,000
LYTS icon
402
LSI Industries
LYTS
$879M
$317K 0.01%
22,256
TSCO icon
403
Tractor Supply
TSCO
$16B
$315K 0.01%
7,300
+280
+4% +$11.4K
AMZA icon
404
InfraCap MLP ETF
AMZA
$468M
$311K 0.01%
8,850
BSVO icon
405
EA Bridgeway Omni Small-Cap Value ETF
BSVO
$2.42B
$309K 0.01%
+14,455
New +$272K
ANET icon
406
Arista Networks
ANET
$212B
$308K 0.01%
5,200
PVH icon
407
PVH
PVH
$3.6B
$308K 0.01%
2,500
-215
-8% -$19.2K
CHH icon
408
Choice Hotels
CHH
$5.09B
$305K 0.01%
2,700
REGN icon
409
Regeneron Pharmaceuticals
REGN
$70.9B
$303K ﹤0.01%
344
STE icon
410
Steris
STE
$21.2B
$303K ﹤0.01%
1,367
+1,000
+272% +$211K
DFAC icon
411
Dimensional US Core Equity 2 ETF
DFAC
$47.4B
$301K ﹤0.01%
10,255
+4,007
+64% +$108K
NXPI icon
412
NXP Semiconductors
NXPI
$67.3B
$299K ﹤0.01%
1,290
BN icon
413
Brookfield
BN
$107B
$297K ﹤0.01%
11,087
+416
+4% +$9.44K
DGRO icon
414
iShares Core Dividend Growth ETF
DGRO
$42.1B
$296K ﹤0.01%
5,484
-575
-9% -$29.2K
FAST icon
415
Fastenal
FAST
$52.2B
$296K ﹤0.01%
9,120
TAK icon
416
Takeda Pharmaceutical
TAK
$54.8B
$296K ﹤0.01%
20,781
OKE icon
417
Oneok
OKE
$58.9B
$295K ﹤0.01%
4,180
+198
+5% +$13.3K
EUSB icon
418
iShares ESG Advanced Universal USD Bond ETF
EUSB
$716M
$293K ﹤0.01%
6,762
-1,045
-13% -$43.4K
D icon
419
Dominion Energy
D
$62.5B
$287K ﹤0.01%
6,106
-500
-8% -$22.3K
SCHO icon
420
Schwab Short-Term US Treasury ETF
SCHO
$12.7B
$287K ﹤0.01%
11,850
+940
+9% +$22.6K
SUSA icon
421
iShares ESG Optimized MSCI USA ETF
SUSA
$4.01B
$284K ﹤0.01%
2,820
XBI icon
422
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$283K ﹤0.01%
3,120
GILD icon
423
Gilead Sciences
GILD
$167B
$281K ﹤0.01%
3,466
-800
-19% -$62.3K
PGR icon
424
Progressive
PGR
$121B
$279K ﹤0.01%
1,760
-630
-26% -$98.6K
LLYVK icon
425
Liberty Live Group Series C
LLYVK
$9.45B
$276K ﹤0.01%
7,375

Similar funds

Bartlett & Co's Q4 2023 Portfolio in Review

As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.66M. The largest sale was Enbridge, an estimated $47.6M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.66M.
  • Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
  • Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
  • Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
  • Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
  • Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
  • Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.